PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Why epigenetic clocks may fail to measure anti-aging effects

“It is not easy to distinguish Type 1 from Type 2, but a clock based on a mixture of Type 1 and Type 2 methylation is likely to produce inconsistent and misleading results, when applied to anti-aging technologies.”

2025-06-10
(Press-News.org)

“It is not easy to distinguish Type 1 from Type 2, but a clock based on a mixture of Type 1 and Type 2 methylation is likely to produce inconsistent and misleading results, when applied to anti-aging technologies.”

BUFFALO, NY — June 10, 2025 — A new research perspective was published in Aging (Aging-US) Volume 17, Issue 5, on May 5, 2025, titled “Methylation clocks for evaluation of anti-aging interventions.”

In this perspective article, Dr. Josh Mitteldorf explores how current epigenetic clocks—used to estimate biological age—might mislead scientists trying to evaluate anti-aging therapies. The paper challenges a widespread assumption: that all changes in DNA methylation with age are equally valid for measuring biological decline. Dr. Mitteldorf proposes that failing to distinguish between different types of epigenetic changes could lead to inaccurate conclusions, potentially even favoring treatments that reduce repair processes rather than extend healthy lifespan.

Methylation clocks have become a popular tool in aging research. These clocks use patterns of DNA methylation, a form of gene regulation that changes over time, to predict a person’s biological age. Because human aging trials are long and expensive, these clocks offer a faster way to evaluate whether a therapy slows or reverses aging. However, this article warns that not all methylation changes are equal in meaning or effect.

The perspective identifies two main categories of methylation changes that occur with age. One type, called ‘Type 1,’ seems to support the idea that aging may be programmed, with gene activity changing in ways that could cause damage, such as more inflammation or increased cell loss. The second type, “Type 2,” involves increased gene activity aimed at repairing age-related damage. If a therapy reduces the activity of Type 2 genes, it may appear to slow aging while actually interfering with the body’s repair response.

“Paradoxically, an intervention that “sets back” the body’s methylation clock to a younger state is shutting off vital repair mechanisms, so it is likely inimical to health and longevity.” 

This distinction is important because most methylation clocks, including popular models like GrimAge, do not separate these two types. As a result, they may incorrectly suggest that a treatment is reversing aging when it is only suppressing beneficial repair mechanisms. According to Dr. Mitteldorf, this could lead researchers to draw the wrong conclusions and unintentionally slow down progress in anti-aging research.

The author also addresses a growing trend in the scientific community that aims to explain age-related methylation as random drift rather than directed change. In a pilot analysis using publicly available data, Dr. Mitteldorf attempted to construct a clock based purely on stochastic, or random, changes. The results showed a weak correlation with age, suggesting that random drift is an unreliable basis for assessing biological aging.

Dr. Mitteldorf argues that most age-related methylation changes are likely intentional and regulated, rather than random. If so, epigenetic clocks must be refined to reflect the biological purpose behind methylation shifts. Without distinguishing between changes that indicate damage and those that indicate repair, current clocks may not only mismeasure age but also misguide intervention strategies.

This article highlights the urgent need to improve how methylation data are interpreted before such clocks can reliably assess anti-aging therapies. A clearer understanding of these molecular patterns could help reshape the future of aging research and therapy evaluation.

Read the full paper: DOI: https://doi.org/10.18632/aging.206245

Corresponding author: Josh Mitteldorf – aging.advice@gmail.com

Keywords: methylation, stochastic entropy, programmed aging, aging clock, epigenetic clock

Click here to sign up for free Altmetric alerts about this article.

______

To learn more about the journal, please visit our website at www.Aging-US.com​​ and connect with us on social media at:

Facebook X Instagram YouTube LinkedIn Reddit Bluesky Pinterest Spotify, and available wherever you listen to podcasts

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

END



ELSE PRESS RELEASES FROM THIS DATE:

Sudy shows that existing drug class may help patients with skin cancer that resists standard treatments

2025-06-10
Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.  Publishing in the journal Cancer Research online June 10, the study featured data generated from experiments with human tissues and cells from patients with advanced melanoma that were implanted into mice. Results uncovered therapeutic targets that could limit melanoma growth in patients whose cancer failed to respond to initial ...

CT colonography beats stool DNA testing for colon cancer screening

2025-06-10
OAK BROOK, Ill. – Compared to stool DNA testing, researchers found that CT colonography is a cost-saving and clinically effective method for colorectal cancer screening, according to a study was published today in Radiology, a journal of the Radiological Society of North America (RSNA). Colorectal cancer is the second leading cause of cancer-related death globally. Routine screening of the colon and rectum can aid in the detection and removal of precancerous polyps, mitigating the need for advanced-stage cancer treatments and the added costs associated with said treatments. Due to the disturbing trend of colorectal cancer diagnoses ...

International oncology experts meet in Kenya to address regional cancer needs

2025-06-10
NAIROBI, KENYA [June 10, 2025] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is joining the African Cancer Coalition (ACC) to update cancer treatment recommendations during the American Cancer Society (ACS) 2025 Global Academy Regional Workshop: Sub-Saharan Africa, in Nairobi, Kenya, June 9-11. The ACS Global Academy Regional Workshop brings together oncology specialists from around the world to improve treatment and support for people with cancer. The three-day workshop includes two days devoted to updating NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) ...

Confusing food labels are costing Australians, new research says it’s time for industry to act

2025-06-10
New research from RMIT University and End Food Waste Australia reveals confusing food labels are driving Australians to throw away perfectly edible food, costing households money and contributing to the nation’s food waste problem. The study reveals clearer, more consistent date labels and storage advice with related bigger print and simple icons, could drastically reduce the amount of edible food Aussies throw away. Each year, Australians waste 7.6 million tonnes of food, much of it still safe to eat. The study showed poor label design and inconsistent packaging ...

First clinical practice guideline on lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults is published

2025-06-10
The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle interventions at the forefront of type 2 diabetes and prediabetes care. “Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults,” offers a comprehensive and evidence-based roadmap for clinicians to effectively incorporate therapeutic lifestyle behavior interventions as a mainstay of treatment, while also complementing existing guidelines for diabetes, many of which mention lifestyle as part of care but often do not provide specifics. The guideline was published in the American Journal ...

People with COVID-like symptoms took up to nine months post-infection to regain mental well-being

2025-06-10
New research finds that people with COVID-like symptoms returned to optimal physical well-being an average of three months after infection, but took up to nine months to return to top mental well-being.  Even one year after infection about 20% of study participants continued to experience overall suboptimal health-related quality of life (HRQoL). The study, to be published June 10 in the peer-reviewed Open Forum Infectious Diseases, compared people who sought treatment for COVID-like symptoms, 75% of whom tested positive ...

Mount Sinai receives $3.8 million grant to study new synthetic drugs and opioid overdoses in emergency departments to prevent deaths

2025-06-10
The Icahn School of Medicine at Mount Sinai has been awarded a $3.8 million grant from the National Institute on Drug Abuse, a division of the National Institutes of Health, to study drug overdose cases linked to novel synthetic opioids. This work will help Emergency Department physicians better identify what substances people have taken, the severity of the overdose, and the best treatments to use in cases involving previously unknown or emergent drugs. This grant will be disbursed over five years. “Front-line doctors urgently need better tools and information to manage overdose cases, especially involving synthetic drugs. Our study will give them real-time ...

Invoking civil rights may actually hurt public support for social causes, new study finds

2025-06-10
Framing a cause as a “civil rights” issue may actually decrease public support—even among people who deeply value civil rights. That’s the key finding of a new study published in the American Sociological Review, which challenges long-held beliefs about how best to win public backing for social change. Researchers found that Americans generally feel very positively about the idea of civil rights, in the abstract. However, in describing contemporary issues—like workplace discrimination, food insecurity or ...

The MIT Press acquires University Science Books from AIP Publishing

2025-06-10
The textbook publisher will transfer to the MIT Press as of July 2025 in time for Fall 2025 course adoptions. The MIT Press is proud to announce the acquisition of textbook publisher University Science Books from AIP Publishing, a subsidiary of the American Institute of Physics. University Science Books was founded in 1978 to publish intermediate and advanced level science and reference books by respected authors, published with the highest design and production standards, and priced as affordably as possible. Over the years, USB’s ...

Interactive artificial pancreas better controls type 1 diabetes using digital twins, study finds

2025-06-10
New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing bodies – and lets users test changes to how the system operates – improved control of their type 1 diabetes, a study has found. The Adaptive Biobehavioral Control (ABC) technology optimizes the automated insulin delivery system in the artificial pancreas every two weeks while giving users access to a “digital twin” computer simulation to test different approaches to managing ...

LAST 30 PRESS RELEASES:

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming

New research casts doubt on ancient drying of northern Africa’s climate

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

American College of Cardiology issues guidance on weight management drugs

Understanding the effect of bedding on thermal insulation during sleep

Cosmic signal from the very early universe will help astronomers detect the first stars

With AI, researchers find increasing immune evasion in H5N1

Study finds hidden effects of wildfires on water systems

Airborne fungal spores may help predict COVID-19 & flu surges

[Press-News.org] Why epigenetic clocks may fail to measure anti-aging effects
“It is not easy to distinguish Type 1 from Type 2, but a clock based on a mixture of Type 1 and Type 2 methylation is likely to produce inconsistent and misleading results, when applied to anti-aging technologies.”